Spruce Biosciences logo

Spruce Biosciences

Treatments for diseases affecting the hypothalamic-pituitary-adrenal (HPA) axis

1

Funding Rounds

$88.0m

Money raised

Overview

Treatments for diseases affecting the hypothalamic-pituitary-adrenal (HPA) axis

Funding series

Funding Series Analysis

The company Spruce Biosciences has raised a total of $88m in funding over 1 rounds.

Key Insights:

  • Spruce Biosciences Series B round, February 2020: $88m
Spruce Biosciences logo
Spruce Biosciences Series B round, February 2020 $88m

Industries

Spruce Biosciences is active in the following industries: